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Adenocarcinoma of the oesophagus is increasing in a number of
regions throughout the world, whilst the incidence of gastric carci-
noma is decreasing (Blot et al, 1991; McKinney et al, 1995;
Thomas et al, 1996; Hansen et al, 1997). Indeed, it has been
claimed that the ratio of oesophageal to gastric adenocarcinoma
has increased from 1:40 in the 1940s to 1:4 in the 1980s (Locke
et al, 1995). Despite the apparent overall decline in carcinoma of
the stomach, increases in carcinoma of the proximal stomach
(Craanen et al, 1992) and of the gastric cardia (Powell and
McConkey, 1990) have been reported. Although these increases
appear contradictory, the cardia is that part of the stomach closest
to and conjoined with the oesophagus. It is therefore possible that
adenocarcinoma of the oesophagus and of the gastric cardia may
represent the same disease, and the classification of adenocarci-
nomas of the cardia as gastric carcinomas may be misleading. We
addressed this issue by detailed examination of changes in the
epidemiological and clinical features of oesophageal and gastric
carcinoma occurring in a single population of 2.5 million over a
20-year period.
MATERIALS AND METHODS
Identification and classification of cases
The Merseyside and Cheshire Cancer Registry (MCCR) provided
clinical and pathological details on all registered cases of primary
oesophageal and gastric carcinoma occurring in local residents
between 1974 and 1993.
The ICD-O classification (version 2; Percy et al, 1990) was used
to subdivide carcinomas by subtype and subsite, but is unsatisfac-
tory in the distal stomach, where some subsites overlap. Therefore
in this study the ICD-O classification for gastric tumours was
simplified into cardia, fundus and subfundus groups as shown in
Table 1.
Data verification
MCCR data derive from pathology reports, hospital case notes and
death certificates, and are checked by registration officers before
being entered onto a computerized database. Additionally, system-
atic validity checks were performed by one of the authors (KD)
through review of abstracted hospital case notes and pathology
reports, as follows. Subtype and subsite classification checks were
performed on 100 cases (2%) of oesophageal carcinoma and 200
cases (2%) of gastric carcinoma randomly (every 50th case)
selected from tables compiled by subtype or subsite. The
oesophageal sample was stratified by subtype and comprised 25
cases each of adenocarcinoma and squamous cell carcinoma
(SCC), and 50 cases of unspecified subtype (Table 2). As most
primary carcinomas of the stomach are adenocarcinomas, gastric
carcinomas were stratified according to subsite (rather than
histological subtype). The sample of gastric cases comprised 25
cases from each subsite of the stomach, and 50 cases of unspeci-
fied subsite (Table 2). Data on 98 cases of gastric carcinoma
classified as SCCs were also checked opportunistically, as this
number of cases appeared suspiciously high.
Opportunistic validity checks were also performed on
abstracted hospital case notes of patients recorded as ‘alive’
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10 years after the diagnosis of carcinoma, comprising 76 cases
(1.4%) of oesophageal carcinoma and 142 cases (1.3%) of gastric
carcinoma.
Data analysis
The annual subtype-specific and subsite-specific incidences of
oesophageal and gastric carcinomas from 1974 to 1993 were
calculated as cumulative rates (0–79 years). The cumulative rate
was calculated as the sum of the age-specific incidence rates for
each year from birth to 79 years, and estimates the cumulative risk
of developing the disease before the age of 79 years.
All histologically proven cases of adenocarcinoma of the
oesophagus and stomach in which the subsite was also specified
were extracted from the data, and subdivided into four groups
according to subsite: upper two-thirds of the oesophagus, lower
one-third of the oesophagus, cardia and subcardia (fundus and
subfundus combined) of the stomach. A comparison of all identifi-
able epidemiological and clinical features of adenocarcinoma at
these four subsites was then performed.
Statistical analysis
Linear regression was used to study the changes in incidence over
time. Comparisons between different subtypes and between
different subsites were performed using c2 tests, the exception
being age at diagnosis, which was compared using Mann–Whitney
U-test. The Kaplan–Meier method was used to determine survival,
and log-rank tests to compare survival at different subsites.
RESULTS
Identification of cases
There were 5322 cases of primary oesophageal carcinoma and
10 535 cases of primary gastric carcinoma registered between
1974 and 1993 (Tables 3 and 4). Histological proof of diagnosis
was obtained in 69% of oesophageal cases and 56% of gastric
cases, although in the last quinquennia studied (1989–1993), this
had risen to 72% and 71% respectively.
Table 1
Subtype Subsite
ICD-O This study ICD-O This study
Oesophagus Adenocarcinoma Adenocarcinoma Upper third Upper third
Squamous cell Squamous cell Cervical Upper third
NOS Unspecified Middle third Middle third
Undifferentiated Others Abdominal Lower third
Adenosquamous Others Lower third Lower third
Small cell Others Overlapping Overlapping
aThoracic Unspecified
NOS Unspecified
Stomach Adenocarcinoma Adenocarcinoma Cardia Cardia
NOS Unspecified Fundus Fundus
Undifferentiated Other Body Subfundus
Squamous cell Others Greater Subfundus
Small cell Others Lesser curve Subfundus
Carcinoid Others aAnterior Subfundus
aPosterior Subfundus
Antrum Subfundus
Pylorus Subfundus
NOS Subfundus
NOS, not otherwise specified. aWe described these as unspecified as the numbers were few (nine in the whole
study), and it is unclear how many upper third and lower third carcinomas might have been included in this subsite
category.
Table 2 Data verification of 100 oesophageal carcinomas and 200 gastric carcinomas
Oesophagus Stomacha
Adenob SCCc Unspecd Total Cardia Fundus Body Greater curve Lesser curve Overlapping Unspecd Total
No. checked 25 25 50 100 25 25 25 25 25 25 50 200
No. correct 24 25 47 95 19 22 23 24 23 18 42 171
Subtype error 0 0 3 3 0 0 0 0 0 0 0 0
Subsite error 1 0 1 2 6 3 2 1 2 7 8 29
a Using original classification (ICD-O, Percy et al, 1990) held by MCCR; badenocarcinoma; csquamous cell carcinoma; dunspecified.836 K Dolan et al
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Data verification
Data verification revealed that three of 100 oesophageal carci-
nomas had been mis-classified by subtype (all three had been clas-
sified as unspecified, but were adenocarcinomas), and that two of
100 had been mis-classified by subsite (both were carcinomas of
the cardia, Table 2). There were no errors of subtype classification
in 200 cases of gastric carcinoma examined. However, 29 cases
(15%) contained errors of subsite classification, mostly occurring
in tumours originally classified as cardia, overlapping or unspeci-
fied subsites. On review of pathology reports and hospital records,
the subsite of origin was identified in eight of 50 (16%) cases orig-
inally classified as unspecified, with one case originating in the
cardia, and seven cases in the subcardia. Of 25 cases originally
classified as cardia, five (20%) were actually carcinomas of the
lower oesophagus; the mis-classification of lower oesophageal
tumours as carcinomas of the cardia was the most common error
detected by data verification.
Of 98 cases originally classified as SCCs of the stomach,
pathology reports were available for 85 cases (87%): 66 cases
(67%) were SCC arising in the oesophagus, four (4%) cases were
adenocarcinomas of the stomach and four (4%) did not have a
histological diagnosis (unspecified). All of these cases were
recoded correctly. A further two cases originated outside the upper
gastrointestinal tract (larynx and anus) and were excluded from the
analysis, leaving nine cases (9%) classified as SCC of the stomach.
The remaining 13 cases (13%) in which pathology reports were
not available remained classified as SCCs of the stomach.
Validity checks on abstracted hospital case notes of patients
alive 10 years after the diagnosis of carcinoma revealed that nine
of 76 cases (12%) of oesophageal carcinoma, and 23 of 142 cases
(16%) of gastric carcinoma, had died. These were recoded
correctly.
Histological and subsite classification
Over the 20-year study period, there were more SCC (1922) than
adenocarcinomas (1532) of the oesophagus (Table 3). The ‘other’
subgroup consisted predominantly of undifferentiated (96), small
cell (47) and adenosquamous (18) carcinomas. About one-third
(1689) of oesophageal carcinomas were classified as unspecified
subtype, although data verification suggests that subtype was
known in 6% of a random sample of these cases. Almost one-half
(767) of carcinomas of unknown subtype were registered by death
certificate; with routine tracking back, MCCR usually gains
complete information in two-thirds of such cases (Seddon and
Williams, 1997). Overall, oesophageal carcinomas of unspecified
subtype had a similar male to female ratio, and a similar upper to
middle to lower subsite ratio as oesophageal carcinomas in total
(Table 3), and so were also likely to contain a similar subtype
ratio. Patients with carcinomas of unspecified subtype were older
(P < 0.0001, Mann–Whitney U-test), and less likely to have
Table 3 Sex, age and subsite details on the histological subtypes of all cases of oesophageal carcinoma from 1974 to 1993 inclusive
Adenocarcinoma (%) Squamous (%) Unspecified (%) Others (%) Total (%)
Total cases 1532 (29) 1922 (36) 1689 (32) 179 (3.4) 5322
Sex Male 1160 (76) 817 (42) 899 (53) 102 (57) 2978 (56)
Female 372 (24) 1105 (58) 790 (47) 77 (43) 2344 (44)
Age (years) Median 68 69 75 68 70
Range 25–95 32–101 34–100 43–94 25–101
Subsite Upper 31 (2) 210 (11) 79 (5) 11 (6) 331 (6)
Middle 122 (8) 540 (28) 208 (12) 39 (22) 909 (17)
Lower 1023 (67) 688 (36) 474 (28) 81 (45) 2266 (43)
Overlapping 34 (2) 44 (2) 26 (2) 6 (3) 110 (2)
Unspecified 322 (21) 440 (23) 902 (54) 42 (24) 1706 (32)
Not treated 555 (36) 660 (34) 1156 (68) 83 (46) 2459 (46)
too advanced 412 (74) 450 (68) 558 (48) 63 (76) 1483 (60)
unfit 95 (17) 131 (20) 259 (23) 15 (18) 500 (20)
not known 48 (9) 79 (12) 339 (29) 5 (6) 471 (19)
DC registereda 203 (13) 231 (12) 767 (45) 27 (15) 1226 (23)
a Cases registered from death certificates; MCCR tracks death certificates back to complete records in two-thirds of cases (Seddon and Williams, 1997)
Table 4 Sex, age and subtype details on the subsites of all cases of gastric carcinoma from 1974 to 1993 inclusive
Cardia (%) Fundus (%) aP-value Subfundus (%) bP-value cUnspec (%) Total (%)
Total cases 1508 (14) 386 (4) 2816 (27) 5825 (55) 10535
Sex Male 1090 (72) 245 (64) 0.004 1760 (63) < 0.00001 3182 (55) 6267 (60)
Female 418 (28) 141 (36) 1056 (37) 2653 (45) 4268 (40)
Age (years) Median 69.0 70.0 0.0006 71.0 < 0.00001 73 72
Range 24–101 24–95 19–101 20–103 19–103
Subtype dAdenoca 1130 (75) 195 (51) < 0.0001 1871 (66) < 0.00001 2128 (37) 5324 (50)
cUnspec 333 (22) 179 (46) 822 (29) 3598 (62) 4932 (47)
Others 45 (3) 12 (3) 123 (4) 99 (2) 279 (3)
aP-value represents statistical comparison of carcinoma of the cardia and of the fundus, using C2 and Mann–Whitney U-tests; bP-value represents statistical
comparison of carcinoma of the cardia and of the subfundus; cunspecified; dadenocarcinoma.Classification of oesophageal and gastric carcinomas 837
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received treatment (P < 0.0001, c2 test) than other oesophageal
carcinomas (Table 3). Hence, it is reasonable to assume that
patients with carcinomas of unspecified subtype were representa-
tive of the dataset as a whole with regards to subtype and subsite,
although they were older and probably had more advanced
disease. Adenocarcinomas and SCCs had significantly different
male to female ratios at 3:1 (1160:372) and 2:3 (817:1105) respec-
tively (P < 0.0001, c2 test), and significantly different upper:
middle:lower third subsite ratios at 1:4:33 (31:122:1023) and 1:3:3
(210:540:688) respectively (P < 0.00001, c2 test). Notably, 87%
(1023 cases) of oesophageal adenocarcinomas in which the subsite
was specified occurred in the lower third of the oesophagus.
In the stomach, adenocarcinoma represented 94% (5324) of all
histological diagnoses of gastric carcinoma (Table 4). The
remaining histologically verified gastric carcinomas, classified as
‘other’ (259), were almost entirely undifferentiated carcinomas
(231). Sixty per cent (2965) of gastric carcinomas without a histo-
logical diagnosis were registered by death certificate, making
further details difficult to acquire, although it is likely that almost
all of these carcinomas were adenocarcinomas. Regarding subsite
classification, 14% (1508) of gastric carcinomas originated in the
cardia, 4% (386) in the fundus and 27% (2816) in the subfundus,
with 55% (5825) being classified as subsite unspecified (Table 4).
Almost half (2737) of these cases classified as subsite unspecified
were registered by death certificate, again limiting the information
available. Interestingly, the subtype was known in 39% (2227) of
cases in which the subsite was unspecified. Nevertheless, gastric
carcinomas of unspecified subsite were commoner in older
patients (vs gastric carcinomas with specified subsite, P < 0.001,
Mann–Whitney  U-test), and commoner in women (vs gastric
carcinomas with specified subsite, P < 0.001, c2 test), as
were carcinomas arising in the subfundic regions of the stomach
(vs carcinoma of the cardia, P < 0.0001, c2 test, Table 4). For
calculation of subsite-specific incidences, gastric carcinomas of
unspecified subsite were included in the subfundus group, as
previous studies suggest that the majority of gastric carcinomas
occur in the subfundus (Antonioli et al, 1982; Correa, 1994; Locke
et al, 1995), and validity checks on 50 cases of gastric carcinoma
of unspecified subsite revealed mis-classification errors in eight
cases (16%), with seven of these eight cases (88%) actually arising
in the subfundus. Also, classification of all gastric carcinomas
with unspecified subsite as subfundus carcinomas prevents over-
estimation of any rise in the incidence of carcinoma of the cardia.
Temporal trends in incidence
From 1974 to 1993, the cumulative incidence (0–79 years) of
oesophageal carcinoma increased significantly in males from 1.25
to 1.72% (P = 0.008, linear regression), and remained relatively
constant in females at 0.7%.
The increase in oesophageal carcinoma from 1974 to 1993 was
due to a rapid rise in adenocarcinoma, the cumulative incidence
(0–79 years) of which increased from 0.32 to 0.85% in males (P <
0.00001, linear regression), and from 0.07 to 0.14% in females (P <
0.0001, linear regression, Figure 1). The cumulative incidence
(0–79 years) of SCC of the oesophagus remained relatively
constant in males at 0.43%, and increased significantly in females
from 0.37 to 0.39% (P = 0.004, linear regression, Figure 1). In the
last 5 years of the study, the male:female ratios for adenocarcinoma
and SCC of the oesophagus were 5:1 and 1:1 respectively. There
was a small but significant decrease in carcinomas classified as
subtype unspecified in both males (P = 0.02, linear regression) and
females (P = 0.003, linear regression, Figure 1). The annual cumu-
lative rate of oesophageal carcinoma classified as ‘others’ did not
change significantly between 1974 and 1993, and was too small to
be represented on the graph. Analysis of the subsite-specific inci-
dence of oesophageal carcinoma was performed for cases regis-
tered between 1974 and 1992, as a number of cases registered in
1993 had incomplete details on subsite classification. There were
significant increases in the incidence of carcinomas of the upper,
middle and lower thirds of the oesophagus in both males and
females. The largest increases occurred in carcinomas of the lower
third, the cumulative incidence (0–79 years) of which increased
from 0.53 to 0.90% in males (P < 0.0001, linear regression), and
from 0.20 to 0.27% in females (P = 0.0002, linear regression,
Figure 2); these increases reflect the rise in incidence of adenocar-
cinoma, 87% of which occurred in the lower oesophagus.
There was a steady, significant decline in the cumulative
incidence (0–79 years) of gastric carcinoma between 1974 and
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Figure 1 Subtype-specific cumulative rates (%) of oesophageal carcinoma
(3-year rolling averages) in males (A) and females (B) from 1974 to 1993
inclusive. (——) Adenocarcinoma; (– –) unspecified; (– – –) squamous838 K Dolan et al
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1993 in males (3.5 to 2.8%) (P < 0.0001, linear regression), and in
females (1.5 to 1.0%) (P < 0.0001, linear regression). As 94% of
all gastric carcinomas diagnosed by histological means were
adenocarcinomas, analysis of the subtype-specific incidence rates
was not performed. The subsite-specific incidence of gastric carci-
noma for males and females are displayed for 1974 to 1991 only
(Figure 3), as a number of cases registered in 1992 and 1993 had
incomplete subsite details. The only subsite of the stomach which
did not decline in incidence over the study period was the cardia,
the cumulative incidence (0–79 years) of which increased from
0.39 to 0.79% in males (P < 0.0001, linear regression), and from
0.12 to 0.21% in females (P = 0.0001, linear regression, Figure 3).
Towards the end of the study, the male:female ratio for cardia and
for subcardia tumours were 5:1 and 2:1 respectively.
Subsite comparison of adenocarcinoma
The epidemiological and clinical comparison of adenocarcinoma
at four different subsites (upper two-thirds of the oesophagus,
lower third of the oesophagus, cardia and subcardia) was
performed using only data in which both the subtype and subsite
were specified (Table 5). The majority of the subsite data for the
oesophagus were derived from ICD-O classification as upper
(312), middle (909) or lower third (2232), and not cervical (19),
thoracic (nine, all placed within unspecified category because of
uncertain overlap) or abdominal (34), the alternative form of this
classification. Adenocarcinomas of the fundus and of the
subfundus had similar changes in incidence and were similar for
age at diagnosis and sex ratio (Table 4), and so were grouped
together as adenocarcinomas of the subcardia. Adenocarcinomas
of the lower oesophagus and of the cardia had a significantly
greater male predominance than adenocarcinomas elsewhere in the
upper gastrointestinal tract (P < 0.001, c2 test), and both occurred
at a younger age (P < 0.0001, Mann–Whitney U-test, Table 5). As
described above, the incidence of adenocarcinoma of the lower
oesophagus and of the gastric cardia were similar throughout the
20-year study period, both increasing to a similar degree, whilst
carcinomas of the subcardia declined. An almost identical
percentage of patients with adenocarcinoma of the oesophagus and
of the cardia were smokers, and this percentage was significantly
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Figure 2 Subsite-specific cumulative rates (%) of oesophageal carcinoma
(3-year rolling averages) in males (top) and females (bottom) from 1974 to
1992 inclusive. (– – –) Upper one-third; (— –) middle one-third; (——) lower
one-third; (— —) overlapping; (——) unspecified
Figure 3 Subsite-specific cumulative rates (%) of gastric carcinoma (3-year
rolling averages) in males (top) and females (bottom) from 1974 to 1991
inclusive. (——) Cardia; (– – –) fundus; (— –) subfundusClassification of oesophageal and gastric carcinomas 839
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greater than those patients with adenocarcinoma of the subcardia
(P < 0.0001, c2 test). Patients with adenocarcinoma of the lower
oesophagus and of the cardia had similar survival (P = 0.06, log-
rank), and both had significantly worse survival than patients with
adenocarcinoma of the subcardia (P = 0.03, log-rank, Figure 4).
Overall, survival from adenocarcinomas of the oesophagus and
stomach was universally poor at all subsites, with 34%, 31%, 29%
and 21% of patients with adenocarcinomas of the subcardia,
cardia, lower one-third and upper two-thirds of the oesophagus,
respectively, surviving 12 months following diagnosis.
DISCUSSION
The rise in incidence of oesophageal carcinoma in Merseyside and
Cheshire from 1974 to 1993 was almost entirely due to an increase
in adenocarcinoma of the lower third, the incidence of which
trebled in males and doubled in females. There was a decrease in
oesophageal carcinoma in 1985, occurring against a background
of overall increase, and this is likely to reflect data processing arte-
fact when MCCR was undergoing recomputerization. The rise in
oesophageal adenocarcinoma in males is four times greater than
the decrease in carcinomas with unspecified subtype, and so
cannot be explained by increasing diagnostic precision alone.
Carcinomas of unspecified subtype had similar sex and subsite
distributions to oesophageal carcinomas as a whole, and it is
reasonable to assume that the subtype distribution was similar.
Therefore, changes in the incidence of carcinomas of unspecified
subtype is unlikely to have significantly altered the pattern of
changes in subtype-specific incidence. In fact, three errors of
subtype classification identified by validity checks on 100 cases of
oesophageal carcinomas all occurred in adenocarcinomas mis-
classified as unspecified subtype. Subtype mis-classification error
in this study may have masked an even greater rise in adenocarci-
noma of the oesophagus. Increases in the incidence of oesophageal
adenocarcinoma have also been reported in North America (Blot
et al, 1991), Scotland (McKinney et al, 1995) and Norway
(Hansen et al, 1997). Similarly, the increase in incidence of carci-
nomas of the lower third of the oesophagus cannot be fully
accounted for by the much smaller decrease in incidence of carci-
nomas classified as unspecified subsite. The rise in adenocarci-
noma of the lower oesophagus may be underestimated since data
verification revealed that five of 25 cases originally classified as
cardia had actually arisen from the lower oesophagus. These
subsite errors in gastric carcinoma, if representative of all regis-
tered cases, may have caused an overestimation (20% of 1508 =
301 cases) of the increase in carcinoma of the cardia, which
doubled in males and females during the study period. Conversely,
the rise in carcinoma of the cardia may have been underestimated
by the categorization of gastric carcinomas of unspecified subsite
Table 5 Comparison of epidemiological features of adenocarcinoma at different subsites of the upper gastrointestinal tract from the MCCR
dataset 1974 to 1993 inclusive. The upper part of the Table summarizes the data, whereas the lower part provides statistical comparison of
the four subsite groups
Oesophagus Stomach
Upper two-thirds Lower one-third Cardia Subcardia
Total cases 153 1023 1130 2066
Sex Males 99 814 848 1347
Females 54 209 282 719
M:F ratio 1.8 : 1 4 : 1 3 : 1 1.9 : 1
Age (years) Median 69.0 67.0 68.0 70.0
Range 39–92 25–95 24–97 19–101
Incidence Males Increase ´ 1.2 Increase ´ 3 Increase ´ 2.5 Decrease
Females Increase ´ 1.2 Increase ´ 2 Increase ´ 1.8 Decrease
Smoking Yes 54 319 365 685
No 66 384 444 1062
Smokers (%) 45.0 45.4 45.0 39.2
Upper vs lower Lower vs cardia Lower vs subcardia Cardia vs subcardia
Agea NSc NSc < 0.0001 < 0.0001
Sexb < 0.0001 NSc < 0.0001 < 0.00001
Smokingb NSc NSc < 0.0001 < 0.00001
a Mann–Whitney U-test; bc2 test; cP > 0.05.
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as carcinomas of the subcardia, as this group may have included a
small number of carcinomas of the cardia. Data verification
revealed that the subsite was known in eight of 50 gastric carci-
nomas classified as unspecified subsite, with one of eight (12%)
arising in the cardia. Carcinomas of the cardia account for between
0 and 27% of all gastric carcinomas, depending on the years
studied (Antonioli et al, 1982; Correa, 1994; Locke et al, 1995). If
at least 4% (233 cases) of gastric carcinomas of unspecified
subsite in this study were carcinomas of the cardia, as suggested by
data verification and other studies, then this underestimation
would balance the overestimation caused by the mis-classification
of lower oesophageal carcinomas as carcinomas of the cardia.
Thus the increase in incidence of carcinoma of the cardia is likely
to be real. The incidence of carcinoma at all other sites of the
stomach other than the cardia declined during the same time
period, including those originating from the fundus. Other studies
have identified decreases in the incidence of distal gastric carci-
nomas, but have failed to demonstrate changes in incidence of
proximal (cardia and fundus combined) gastric carcinomas (Locke
et al, 1995; Hansen et al, 1997). The stable incidence rates of prox-
imal carcinomas in these studies may have hidden increases in
carcinomas of the cardia and decreases in carcinomas of the
fundus, both of which were evident in our study.
Although the effects of mis-classification can never be
completely overcome in a population-based study, adenocarci-
nomas of the lower oesophagus and of the cardia were strikingly
similar in all the clinical and epidemiological features studied, and
both differed significantly from carcinoma of the subcardia, a
difference that has been previously noted in a non-population
based study of 166 patients (Wang et al, 1986). In order to mini-
mize any classification errors, only adenocarcinomas with a
specified subsite were included in this part of the study. Patients
with adenocarcinoma of the cardia had similar survival to patients
with adenocarcinoma of the lower oesophagus, and both had a
significantly worse survival than patients with adenocarcinoma of
the subcardia. Data describing the TNM (tumour, node, metas-
tasis) classification of carcinomas, a method of assessing stage that
uses the subsite and subtype classification of ICD-O (Spiessl et al,
1992; Sobin and Wittekind, 1997), were not recorded in this popu-
lation-based study, and so we cannot comment on whether a more
favourable stage distribution might account for the better survival
in adenocarcinoma of the subcardia. SEER data from the USA
have also shown that carcinomas of the subcardia have a better
prognosis than carcinomas of the cardia (Thomas and Sobin,
1995). However, survival from adenocarcinoma was poor at all
sites of the oesophagus and stomach. In our study, errors relating
to survival data were similar for both oesophageal and gastric
carcinomas, mainly affecting a minority of long-term survivors,
and therefore not noticeably affecting overall survival. As
discussed, subsite classification errors mainly involved adeno-
carcinomas of the lower oesophagus being registered as adeno-
carcinomas of the cardia. The inclusion of lower oesophageal
adenocarcinomas in the cardia subgroup could contribute to, but is
unlikely to explain all, the similarities between adenocarcinomas
at these subsites; this inclusion also highlights the clinical and
pathological difficulties in distinguishing between them.
The aetiology of adenocarcinoma of both the lower oesophagus
and of the cardia is likely to be associated with gastro-oesophageal
reflux disease and Barrett’s oesophagus (Cameron et al, 1995;
Chow et al, 1995), in particular chronic duodenogastro-
oesophageal reflux resulting in intestinal metaplasia (Caldwell
et al, 1995; Miwa et al, 1996). The rise in incidence of adenocarci-
noma around the gastro-oesophageal junction (GOJ) may reflect
an increased prevalence of gastro-oesophageal reflux disease
(Loof et al, 1993). Adenocarcinomas of the lower oesophagus and
cardia are not related to Helicobacter pylori infection (Ricaurte
et al, 1996), which is significantly more prevalent in patients with
carcinoma of the subcardia (Hansson et al, 1995).
Adenocarcinomas of the lower oesophagus and cardia are also
very similar in their growth pattern, degree of differentiation and
presence of nodal metastases at resection, and, not surprisingly,
the most common complaint in both oesophageal and cardia carci-
nomas is dysphagia, which is present in over 75% of cases (Kalish
et al, 1984). Thus in addition to aetiology, the epidemiology,
clinical features, pathology and survival of adenocarcinomas of
the lower oesophagus and cardia have been shown to be similar in
small studies of selected patients, but our study is the first to
confirm these last four similarities in population-based data. Not
only did we find carcinoma of the cardia to resemble lower
oesophageal carcinoma in all these features, but both were
significantly different from carcinoma of the subcardia.
The remarkable similarity between adenocarcinomas of the
lower oesophagus and of the cardia suggests that the arbitrary divi-
sion of these carcinomas into oesophageal and gastric carcinomas
is inappropriate. Previous pathological subsite classifications
based on resected specimens have involved determination of the
centre of the carcinoma and measurement of the distance to the
GOJ (Holscher et al, 1995), or have required estimation of where
the majority of the carcinoma is situated (Tachimori et al, 1996).
Indeed, the identification of the origin of a tumour around the GOJ
can be even more difficult preoperatively, especially in the pre-
sence of a hiatus hernia and/or Barrett’s oesophagus, where the site
of the GOJ and cardia may be difficult to determine endoscopi-
cally or radiologically (Spechler and Goyal, 1986; Csendes et al,
1993). In the presence of chronic inflammatory changes resulting
from gastro-oesophageal reflux disease, it may even be difficult to
determine the precise location of the cardia by histological means
(Riddell, 1996). It is therefore not surprising that, in our study, data
verification identified a number of cases of subsite mis-classifica-
tion involving carcinoma of the lower oesophagus and gastric
cardia. Indeed, subsite mis-classification of carcinomas around the
GOJ would appear inevitable within the present ICD-O classifica-
tion scheme, which does not code carcinoma of the GOJ as a
distinct entity, and which also includes overlapping subsites for
carcinomas of the stomach. Furthermore, ICD-O contains two
alternative subsite classifications for oesophageal carcinoma
(cervical, thoracic and abdominal versus upper, middle and lower)
within ICD-O, adding further confusion. This study shows how
infrequently the first of these two alternatives is used. Yet the ICD-
O scheme for the oesophagus and stomach is identical to that of
ICD 9 and ICD 10 on which it is based (Percy et al, 1990), is the
international standard, is preferred by the International Agency for
Research on Cancer of the World Health Organization, and is the
most widely used within cancer registries worldwide (Whelan and
Young, 1997). In addition, the most recent version of ICD-O
(Percy et al, 1990) failed to address the difficulties of classification
discussed above.
In view of these difficulties, and of the recent evidence of simi-
larities between carcinomas of the lower oesophagus and cardia, a
new subsite classification of carcinomas of the upper gastroin-
testinal tract from the pharynx to the duodenum is needed. An
alternative classification for carcinomas around the GOJ hasClassification of oesophageal and gastric carcinomas 841
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recently been described in which carcinomas are subdivided into
lower oesophageal, GOJ and cardia depending on the distance
from the centre of the carcinoma to the GOJ (Siewert and Stein,
1996, 1998). Unfortunately, as the distances to the GOJ may be
small and the carcinomas may be large, this classification is diffi-
cult to implement when the diagnosis is made by endoscopy only
and the patient does not undergo surgical resection, which is the
situation in the majority of cases (Stipa et al, 1992). Furthermore,
our study has shown that the use of cardia as a subsite for
carcinomas around the GOJ is prone to error, principally due to
difficulties in determining its precise location, as discussed above.
Our study also suggests that difficulties exist with implementation
of the ICD-O subsite classification for carcinomas of the stomach,
as 39% of gastric carcinomas classified as subsite unknown
actually had a histological diagnosis, indicating that, despite an
endoscopy, the subsite could still not be accurately identified in a
number of cases. Hence, we propose a simpler pragmatic
‘Liverpool’ classification that can be applied to tumours diagnosed
endoscopically, and takes into account these new findings.
Carcinomas of the upper gastrointestinal tract between the
pharynx and the duodenum should be initially classified into carci-
nomas of the oesophagus, GOJ and stomach, as shown in Table 6.
Oesophageal carcinomas occur below the cricopharyngeal
sphincter and above the GOJ, and should be subdivided into upper,
middle and lower thirds. When upper tumours become middle, and
middle tumours become lower, is and will be determined grossly
at endoscopy in the majority of patients, for which detail is given
in Table 6 as a guide. Any carcinoma that encroaches upon the
GOJ from above or from below should be classified as GOJ, and
will therefore include some of the carcinomas previously classi-
fied as lower oesophageal and the majority of carcinomas previ-
ously classified as cardia. Further subsite division of carcinomas
of the GOJ, as proposed by Siewert and Stein (1996, 1998) would
be impossible to implement by endoscopy, and may also be diffi-
cult to implement for those patients undergoing resection of large
carcinomas. Carcinomas below the GOJ that do not involve the
GOJ should be classified as gastric, which should be subdivided
into proximal, distal and overlapping subsites. Carcinomas of the
fundus were similar both clinically and epidemiologically to carci-
nomas of the subfundus, the majority of which in our study were
carcinomas of the body of the stomach; carcinomas of the fundus
and of the body of the stomach are therefore grouped together as
proximal carcinomas. The difficulties encountered with the ICD-O
subsite classification prevented detailed analysis of carcinomas at
different subsites of the stomach, particularly carcinomas of the
pylorus and antrum, where again there exists a degree of overlap.
The ‘Liverpool’ system simply classifies all carcinomas distal to
the incisura angularis, which is easily identified on endoscopy, as
distal carcinomas. Distal carcinomas would therefore replace
carcinomas of the pylorus and antrum, and implementation of this
classification would permit future clinical and epidemiological
comparisons of proximal and distal carcinomas, which is difficult
under the present ICD-O system. Overall, use of the ‘Liverpool’
classification would make registration of carcinoma of the oesoph-
agus and stomach simpler and more accurate, thereby clarifying
the epidemiological surveillance of upper gastrointestinal carci-
nomas, and is in step with changes in diagnostic techniques.
Accurate histological and subsite classification of upper
gastrointestinal carcinomas is important in determining treatment.
The extent of surgical resection for carcinoma around the GOJ
remains to be determined (Stipa et al, 1996), as does the role of
chemoradiotherapy (Hennessy, 1996). Part of the difficulty in
determining appropriate treatment for carcinoma around the GOJ
stems from problems in comparing results from different series, in
turn partly the result of the lack of an accurate subsite classifica-
tion system (Stipa et al, 1992). The widespread application of our
proposed subsite classification to carcinoma of the oesophagus
and stomach would aid the planning and interpretation of future
treatment trials for carcinoma of the GOJ.
In summary, this study confirms a simultaneous, dramatic
increase in the incidence of adenocarcinoma of the lower oesoph-
agus and of the gastric cardia in the last 20 years. Despite the
confusion created by the present ICD-O classification of carci-
noma at the GOJ, it is apparent that adenocarcinoma of the lower
oesophagus and of the cardia are similar in aetiology, epidemi-
ology and clinico-pathological features; it is compelling evidence
that they are the same disease. This is taken into account in a new
subsite classification of carcinoma of the oesophagus and of the
stomach, which includes a category for carcinoma of the GOJ. Use
of this new subsite classification is likely to help clarify the
changing epidemiology of carcinomas of the oesophagus and
stomach, and to allow comparison of different treatment strategies
for these carcinomas.
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